Brief: Sensei Biotherapeutics Reports Q3 Results

Faeth Therapeutics,

08/11/2022 12:57

Nov 8 (Reuters) - Sensei Biotherapeutics Inc  SNSE.O :
    * SENSEI BIOTHERAPEUTICS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
    * QTRLY LOSS PER SHARE $0.44
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE
$116.6
MILLION AS OF SEPTEMBER 30
    * NS-101 PRECLINICAL DATA DEMONSTRATE A FAVORABLE
PHARMACOKINETIC
PROFILE
    * SNS-101 PRECLINICAL DATA DEMONSTRATE EVIDENCE OF ADVANCED
ANTI-TUMOR EFFECTS AND A SUPERIOR CYTOKINE RELEASE PROFILE

Source text for Eikon:  ID:nGNXNgnRd 
Further company coverage:  SNSE.O 
 ((Reuters.Briefs@thomsonreuters.com;))